Pathstone Holdings
ELDN icon

Pathstone Holdings’s Eledon Pharmaceuticals ELDN Stock Holding History

Pathstone Holdings’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,464
Closed -$79.8K – 2355
2025
Q2 		$79.8K Sell
29,464
-10,350
-26% -$31.1K ﹤0.01% 2132
2025
Q1 		$135K Hold
39,814
– – ﹤0.01% 2128
2024
Q4 		$164K Buy
39,814
+26,785
+206% +$106K ﹤0.01% 2198
2024
Q3 		$32.4K Hold
13,029
– – ﹤0.01% 2306
2024
Q2 		$34.4K Hold
13,029
– – ﹤0.01% 2278
2024
Q1 		$26.8K Hold
13,029
– – ﹤0.01% 2279
2023
Q4 		$23.5K Buy
+13,029
New +$18.1K ﹤0.01% 2186

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ZP
Zimmer Partners New York $4.08B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return